Living-donor lobar lung transplantation for bronchiolitis obliterans after Stevens-Johnson syndrome  by Date, Hiroshi et al.
Brief Communications
The Journal of Thoracic and Cardiovascular Surgery • Volume 123, Number 2   389
From the Departments of Surgery II,a Anesthesiology and Resuscitology,b and
Cardiovascular Surgery,c Okayama University School of Medicine, Okayama,
Japan.
Received for publication July 11, 2001; accepted for publication July 26, 2001.
Address for reprints: Hiroshi Date, MD, Department of Surgery II, Okayama
University School of Medicine, 2-5-1 Shikata-Cho, Okayama 700-8558, Japan
(E-mail: hdate@nigeka2.hospital.okayama-u.ac.jp).
J Thorac Cardiovasc Surg 2002;123:389-91
Copyright © 2002 by The American Association for Thoracic Surgery
0022-5223/2002 $35.00 + 0 12/54/119331
doi:10.1067/mtc.2002.119331
Living-donor lobar lung transplantation for bronchiolitis obliterans
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Stevens-Johnson syndrome (SJS) is an acute self-limitederuption of the skin and mucous membranes that repre-sents a hypersensitivity reaction to various etiologicagents.1 Underlying causes include exposure to drugs,
various microbial diseases, malignant tumors, and connective tis-
sue diseases. Specific involvement of bronchial epithelium is rela-
tively uncommon but indicates a poor prognosis.2 As a conse-
quence of airway epithelial injury, bronchiolitis obliterans can
occur.3
To our knowledge, this is the first reported case of living-donor
lobar lung transplantation for bronchiolitis obliterans associated
with SJS.
Clinical Summary 
A 13-year-old boy who was well until September 16, 2000,
received oral medication (cefcapene pivoxil hydrochloride, aman-
tadine hydrochloride) for an upper respiratory tract infection.
Twenty-four hours later, he had redness in both eyes followed by
a generalized erythematous maculopapular skin rash with high-
grade intermittent fever. The rash progressed to become vesicu-
lobullous, affecting more than 80% of the body surface area. SJS
was diagnosed clinically and the boy was treated with cortico-
steroid drugs. However, hematuria developed and mechanical ven-
tilation was instituted on September 23 because of massive
hemoptysis. The chest computed tomographic scan demonstrated
parenchymal infiltrates caused by pulmonary hemorrhage (Figure
1, A). Bronchoscopic examination revealed ulcerative and exuda-
tive lesions with sloughing of mucosa throughout the respiratory
tree. Therapy was continued with oral prednisolone (80 mg/day)
and there was gradual improvement of skin lesions and respirato-
ry status. Although mechanical ventilatory support was discontin-
ued after a month, he became completely bedridden and required
supplemental oxygen inhalation continuously. In March 2001, the
chest radiograph revealed bilateral hyperlucencies but no signifi-
cant opacities. The chest computed tomographic scan demonstrat-
ed extensive bilateral parenchymal lung disease with pneumato-
cele formation (Figure 1, B).
The patient was transferred to Okayama University Hospital
on March 25, 2001, for possible living-donor lobar lung trans-
plantation. On admission, the patient was sitting on the bed with
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his face pressed deeply down on the pillow. There was marked
nasal flaring with intercostal, subcostal, and supraclavicular
retractions. Auscultation revealed bilateral diffuse wheezing. An
arterial blood gas revealed a pH of 7.31, a PaO2 of 126.7 mm Hg,
and a PaCO2 of 100.2 mm Hg with 7 L/min oxygen administered
via a nasal cannula.
On March 27, 2001, he underwent living-donor lobar lung
transplantation with a right lower lobe from his father (36 years
old) and a left lower lobe from his mother (36 years old). The
heights and weights were 157 cm and 32.3 kg for the recipient, 180
cm and 92.0 kg for the father, and 160 cm and 52.0 kg for the
mother.
Because of the recipient’s poor preoperative condition, partial
cardiopulmonary bypass was initiated by way of the femoral ves-
sels under local anesthesia. Then, the recipient was anesthetized
and intubated. The surgical and logistic aspects of the right and left
donor lobectomy, the donor lobe backtable preservation technique,
and the recipient bilateral pneumonectomy and bilateral lobar
implantation have been previously described by Starnes’ group.4
Histologic section of the excised lung tissue revealed bronchi-
olitis obliterans with total scarring (Figure 2). The lumen of the
bronchiole was obliterated by dense fibrous scar tissue associated
with an inflammatory mononuclear infiltrate.
Figure 1. Preoperative computed tomographic scan of the patient with SJS-associated bronchiolitis obliterans. A,
Parenchymal infiltrates due to pulmonary hemorrhage in September 2000. B, Pneumatocele formation in March 2001. 
Figure 2. Histologic examination of the excised lung tissue, show-
ing bronchiolitis obliterans with total scarring. The lumen of the
bronchiole was obliterated by dense fibrous scar tissue associat-
ed with an inflammatory mononuclear infiltrate (hematoxylin-
eosin stain, original magnification ×50).
Figure 3. Chest x-ray film 1 month after living-donor lobar lung
transplantation. Well-expanded grafts filled the chest cavity,
leaving no detectable dead space without cardiomegaly.
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The postoperative course was relatively uneventful. Immuno-
suppression comprised a triple drug therapy consisting of cyclo-
sporine, azathioprine, and prednisone. The patient was completely
weaned from the respirator within 2 days. An episode of acute
rejection required high-dose methylprednisolone intravenously.
One month postoperatively, the chest x-ray film demonstrated
well-expanded grafts with no detectable dead space (Figure 3).
The patient was discharged from the hospital 46 days after trans-
plantation. Three months postoperatively, he had returned to nor-
mal life and was able to carry out daily activities. He is in good
physical condition with a vital capacity of 1.75 L (66.3% of pre-
dicted), a forced expiratory volume in 1 second of 1.48 L, and an
arterial oxygen tension of 102.9 mm Hg while breathing room air.
Discussion 
SJS is a severe mucocutaneous eruption that can feature visceral
involvement and cause significant morbidity and mortality.1 Both
infectious agents and medications can cause SJS. In this case,
drugs (cefcapene pivoxil hydrochloride, amantadine hydrochlo-
ride) for an upper respiratory tract infection were the offending
agents. The immunopathogenesis of SJS is believed to involve ker-
atinocyte apoptosis, a scenario similar to graft-versus-host dis-
ease.5 When greater than 30% of the total body surface area is
involved, the disease is called toxic epidermal necrolysis. Lebargy
and associates2 evaluated the incidence and prognosis of pul-
monary complications associated with toxic epidermal necrolysis
in 41 consecutive patients. They reported that 10 (24%) patients
had bronchial injury and 7 (17%) patients died. The pathogenesis
of chronic pulmonary sequelae in SJS or toxic epidermal necroly-
sis is not well understood. Whether the cause is primary infection,
mucosal damage due to immune complex deposition, or a combi-
nation of both is unclear.
There were obvious concerns regarding whether lung transplan-
tation would be feasible for this particular patient. SJS could recur,
because many kinds of medication would be used during and after
transplantation. We avoided the use of cephalosporins and
antipyretic drugs. Since the patient had had a hypersensitivity reac-
tion to some drugs, immediate rejection of the lung grafts might
occur. An acute rejection episode on day 8 was easily managed by
bolus injection of methylprednisolone. Bronchiolitis obliterans
might recur in a more accelerated manner after transplantation
because this condition is known to be a feature of chronic rejection.
Close monitoring of pulmonary function is mandatory. 
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